Functional heterogeneity of airway mast cells

Allergy: European Journal of Allergy and Clinical Immunology, Supplement

Volumn 54, Issue 57, 1999, Pages 50-62

  Okuda, Minoru ^a,b  

^a NIPPON MEDICAL SCHOOL   (Japan)

^b NONE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIMYCIN; CD40 ANTIGEN; CELL ADHESION MOLECULE; CHEMICAL AGENT; CHEMOTACTIC FACTOR; COMPOUND 48-80; CORTICOSTEROID; CROMOGLYCATE DISODIUM; CYTOKINE; DRUG; HISTAMINE; HISTAMINE H1 RECEPTOR ANTAGONIST; IMMUNOGLOBULIN E; IMMUNOGLOBULIN E ANTIBODY; KININ; LEUKOTRIENE; NEDOCROMIL; SUBSTANCE P; TERFENADINE;

ALLERGIC REACTION; ALLERGIC RHINITIS; BASOPHIL; CELL FUNCTION; CELLULAR DISTRIBUTION; FIBROSIS; HUMAN; HUMAN CELL; IMMUNOGLOBULIN PRODUCTION; IMMUNOTHERAPY; INFLAMMATORY CELL; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; MAST CELL; MAST CELL DEGRANULATION; PHENOTYPE; PRIORITY JOURNAL; REVIEW; TISSUE DISTRIBUTION;

ANIMALS; FIBROSIS; GUINEA PIGS; HISTAMINE ANTAGONISTS; HUMANS; HYPERSENSITIVITY; IMMUNOGLOBULIN E; LUNG; MAST CELLS; NASAL MUCOSA;

EID: 0032747909     PISSN: 01081675     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (80)

1. 1. Bienenstock J, Befus D, Denburg J, et al. Comparative aspects of mast cell heterogeneity in different species and sites. Int Arch Allergy Appl Immunol 1985;77:126-129.
2. 2. Gibson PG, Allen CJ, Yang JP, et al. Intra-epithelial mast cells in allergic and nonallergic asthma. Am Rev Respir Dis 1993;148:80-86.
3. 3. Okuda M, Yen CH, Okubo K, Fooanant S, Ikeda M, Pawankar R. Intra-epithelial cell population in the allergic nasal mucosa. Am J Rhinol 1991;5:219-225.
4. 4. Xaubet A, Moises JA, Agusti C, Martos A, Picado C. Identification of mast cells in bronchoalveolar lavage fluid. Eur J Allergy Clin Immunol 1991;46:222-227.
5. 5. Peter SP, Schulman ES, Schleimer RP, et al. Dispersed human lung mast cells. Am Rev Respir Dis 1992;126:1034-1039.
6. 6. Enerbäck L. Mast cell heterogeneity. In: Befus AD, Bienenstock J, Denburg J, editors. Mast cell diferentiation and heterogeneity. New York: Raven Press, 1986:1-25.
7. 7. Okuda M, Sakaguchi Y, Suzuki F, Otsuka H, Kawabori S. Ultrastrucural heterogeneity of basophilic cells in the allergic nasal mucosa. Ann Allergy 1995;54:152-157.
8. 8. Matsuda T. Ultrastructural study of the mast cell degranulation from the patients with allergic respiratory disease. Jpn J Allergol 1987;36:49-55.
9. 9. Fridman MM, Kaliner MA. Human mast cells and asthma. Am Rev Respir Dis 1987;135:1157-1164.
10. 10. Okuda M, Otsuka H, Kawabori S. Characteristics and role of the surface basophilic cells in nasal allergy. In: Veldman JE, McCabe BF, Huizing EH, Mygind N, editors. Immunobiology, autoimmunity and transplantation in otorhinolaryngology. Amsterdam: Kugler Pub., 1985:267-272.
11. 11. Okuda M, Otsuka H, Kawabori S. Basophil leukocytes and mast cells in the nose. Eur J Respir Dis 1983;64(Suppl. 128):7-14.
12. 12. Liu M. Seasonal variation of nasal surface basophilic cells and eosinophils in Japanese cedar pollinosis. Rhinology 1988;26:167-173.
13. 13. Enerback L, Pipkom U, Granerus G. Intra-epithelial migration of nasal mucosal mast cells in hay fever. Int Arch Allergy Appl Immunol 1986;80:44-51.
14. 14. Enerbäck L, Karlsson G, Pipkom U. Nasal mast cell response to natural allergen exposure. Int Arch Allergy Appl Immunol 1989;88:209-211.
15. 15. Borres MP, Irander K, Bjöksten B. Metachromatic cells in nasal mucosa after allergen challenge. Eur J Allergy Clin Immunol 1990;45:98-103.
16. 16. Irani AA, Schwartz LB. Mast cell heterogeneity. Clin Exp Allergy 1989;19:143-155.
17. 17. Bradding P, Okayama Y, Howarth H, Church MK, Holgate ST. Heterogeneity of human mast cells based on cytokine content. J Immunol 1995;155:297-307.
18. 18. Church MK, Levi-Schaffer F. The human mast cells. J Allergy Clin Immunol 1997;99:155-160.
19. 19. Caughey GH. The structure and airway biology of mast cell proteinases. Am J Respir Cell Mol Biol 1991;4:387-394.
20. 20. Castells M, Schwartz M. Tryptase level in nasal-lavage fluid as an indicator of the immediate allergic response. J Allergy Clin Immunol 1988;348:348-355.
21. 21. Thompson HL, Schulman ES, Metcalf DD. Identification of chondroitin sulfate E in human lung mast cells. J Immunol 1988;140:2708-2713.
22. 22. Stevens RI, Fox CC, Lichtenstein LM, Austen KF. Identification of chondroitin sulfate E proteoglycans and heparin proteoglycans in the secretory granules of human lung mast cells. Immunology 1988;85:2284-2287.
23. 23. Schwarz LB, Irani AA, Roller K, Castells MC, Schechter NM. Quantitation of histamine, tryptase and chymase in dispersed human T and TC cells. J Immunol 1987;138:2611-2615.
24. 24. Bradding P. Human mast cell cytokines. Clin Exp Allergy 1996;26:13-19.
25. 25. Okayama Y, Petit-Frerc C, Kassel O, et al. IgE dependent expression of mRNA for IL-4 and IL-5 in human lung mast cells. J Immunol 1995;155:1796-1808.
26. 26. Pawankar R, Ra C. Heterogeneity of mast cells and T cells in the nasal mucosa. J Allergy Clin Immunol 1996;98:S248-S262.
27. 27. Okuda M, Otsuka H, Kawabori S. Studies of nasal surface basophilic cells. Ann Allergy 1985;54:69-77.
28. 28. Ali H, Leung KBP, Pearce FL, Hayes NA, Foreman JC. Comparison of the E synthesis in B cells by mast cells and basophils. Nature 1993;365:340-343.
29. 29. Lowman MA, Rees PH, Benyon RC, Church MK. Human mast cell heterogeneity. J Allergy Clin Immunol 1988;81:590-597.
30. 30. Otsuka H, Inaba M, Fujikura T, Kunitomo M. Histochemical and functional characteristics of metachromatic cells in the nasal epithelium in allergic rhinitis. J Allergy Clin Immunol 1995;96:528-536.
31. 31. Enerbäck L. Mast cells in rat gastrointestinal mucosa. Acta Path Microbiol Scand 1996;83:4464-4468.
32. 32. Pearce FL. The mast cell. Immunol Allergy Clin N Am 1990;10:251-262.
33. 33. Pearce FL, Befus AD, Gauldie J, Bienenstock J. Mucosal mast cells. J Immunol 1982;128:2481-2486.
34. 34. Okuda M, Ohnishi M, Otsuka H. The effects of cromolyn sodium on nasal mast cells. Ann Allergy 1985;54:721-723.
35. 35. Okayama Y, Beyon RC, Rees PH, Lowman MA, Hillier K, Church MK. Inhibition profiles of sodium cromoglycate and nedocromil sodium on mediator release from mast cells of human skin, lung, tonsil, adenoid and intestine. Clin Exp Allergy 1992;22:401-409.
36. 36. Arunlakshana O, Schild HO. Histamine release by anti-histamines. J Physiol 1953;119:47-48.
37. 37. Fabre JM, Marty-Ane C, Alauzen M, Souques F, Bousque J, Campbell AM. Pharmacologic heterogeneity of human lung and colon cells: effect of terfenadine and cetirizine. Eur J Allergy Clin Immunol 1995;50:362-365.
38. 38. Okayama Y, Beyon RC, Lowman MA, Church MK. In vitro effects of H1-antihistamines on histamine and PGD2 release from mast cells of human lung, tonsil and skin. Eur J Allergy Clin Immunol 1994;49:246-253.
39. 39. Okuda M, Okubo K, Miura I. Mast cell stabilizers for the treatment of allergic rhinitis. In: van Cauwenberge, editor. Proceedings of the XVI Congress of the European Rhinologic Society 1998:8-12.
40. 40. Scernan P. The membrane action of anaesthetics and tranquilizers. Pharmacol Rev 1972;24:583-655.
41. 41. Okuda M, Sakaguchi K, Otsuka H. Intranasal beclomethasone: mode of action in nasal allergy. Ann Allergy 1983;50:116-120.
42. 41. Pipkom U, Enerbäck L. Nasal mucosal mast cells and histamine in hay fever. Int Arch Allergy Appl Immunol 1987;84:123-128.
43. 43. Rak S, Jacobson MR, Sudderick RM, et al. Influence of prolonged treatment with topical corticosteroid on early and late phase nasal response and cellular infiltration in the nasal mucosa after allergen challenge. Clin Exp Allergy 1994;24:930-939.
44. 44. Gomez EVA, Clague JE, Gatland D, Davies RJ. Effect of topical corticosteroids on seasonal increases in nasal mast cells. Br Med J 1988;296:1572-1573.
45. 45. Juliusson S, Aldenborg F, Enerbäck L. Proteinase content of mast cells of nasal mucosa: effects of natural allergen exposure and of local corticosteroid treatment. Eur J Allergy Clin Immunol 1995;50:15-22.
46. 46. Schleimer RP. The effects of antiinflammatory steroids on mast cells. In: Kaliner M, Metcalfe DD, editors. The mast cell in health and disease. New York: Marcel Dekker, 1993:483-511.
47. 47. Rachelefsky GS. Pharmacologic management of allergic rhinitis. J Allergy Clin Immunol 1998;101:S367-S369.
48. 48. Ebner C, Sicmann U, Bohle B, et al. Immunological changes during specific immunotherapy of grass pollen allergy: reduced lymphoproliferative response to allergen and shift from TH2 to TH1 in T-cell clones specific for Phl p1, a major grass pollen allergen. Clin Exp Allergy 1997;27:1007-1015.
49. 49. Till S. Immunotherapy: readdressing the balance between TH2 and TH1 cells. Clin Exp Allergy 1997;27:981-985.
50. 50. Okuda M, Otsuka H, Sakaguchi K, Ohkubo K. Effects of anti-allergic treatment on the nasal surface basophilic metachromatic cells in allergic rhinitis. Allergy Proc 1989;10:23-26.
51. 51. Gauchat J, Henchoz S, Mazzci G, et al. Induction of human IgE synthesis in B cells by mast cells and basophilic metachromatic cells in allergic rhinitis. Nature 1993;365:340-343.
52. 52. Pawankar R, Okuda M, Yssel H, Okumura K, Ra C. Nasal mast cells in perennial allergic rhinitics exhibit increased expression of the FccRI, CD40L, and IL-13, and can induce IgE histamine-releasing action of substance P on mast cells and basophils from different species and tissues. Int Arch Allergy Appl Immunol 1986;79:413-418.
53. 53. Pawankar R, Suzuki K, Okuda M, et al. Increased FccRI expression, cell-bound IgE and IgE-mediated mediator release in nasal mast cells of patients with perennial allergic rhinitis. J Allergy Immunol Otolaryngol 1998;16:7-15.
54. 54. Pawankar R, Okuda M, Okubo K, Ra C. Lymphocyte subsets of the nasal mucosa in perennial allergic rhinitis. Am J Respir Crit Care Med 1995;152:2049-2058.
55. 55. Ishikawa T, Miyashita H, Shimada T. IgE containing cells in allergic nasal mucosa. Jpn J Otolaryngol 1973;76:1095-1099.
56. 56. Kawabori S. The IgE positive cells in human allergic nasal mucosa. Jpn J Immunol Allergol Otolaryngol 1988;6:45-54.
57. 57. Kawabori S, Kanai N, Tosho T, Adachi T. Existence of c-kit receptor-positive, tryptase-negative, IgE-negative cells in human allergic nasal mucosa. Int Arch Allergy Appl Immunol 1997;112:36-43.
58. 58. Okuda M. Pathophysiology of allergic rhinitis. Allergy Clin Immunol News 1989;1:167-177.
59. 59. Kawabori S, Okuda M, Unno T. Mast cells in allergic nasal epithelium and lamina propria before and after provocation. Clin Allergy 1983;13:181-189.
60. 60. Pcsci A, Foresi A, Bertorlli G, Chetta A, Oliveri D. Histochemical characteristics and degranulation of mast cells in epithelium and lamina propria of bronchial biopsies from asthmatic and normal subjects. Am Rev Respir Dis 1993;147:684-689.
61. 61. Naclerio RM, Baroody F. Understanding the inflammatory processes in upper airway disease and asthma. J Allergy Clin Immunol 1988;101:S345-S351.
62. 62. Naclerio RM, Meier HL, Kagey-Sobotka , et al. Mediator release after nasal airway challenge with allergen. Am Rev Respir Dis 1983;128:597-602.
63. 63. Ichikawa K, Okuda M, Naka F, et al. The sources of chemical substance in allergic nasal fluid. Rhinology 1991;29:143-149.
64. 64. Pipkom U, Karlsson G, Enerbäck L. Secretory activity of nasal mucosa mast cells and histamine release in hay fever. Int Arch Allergy Appl Immunol 1988;87:349-360.
65. 65. Otsuka K, Okuda M. Important factors in the nasal manifestation of allergy. Arch Oto-Rhino-Laryngol 1981;223:227-235.
66. 66. Schulman ES, Pollack RB, Post TJ, Peters SB. Histochemical heterogeneity of dispersed human lung mast cells. J Immunol 1990;144:4195-4201.
67. 67. Holgate ST, Kay B. Mast cells, mediators and asthma. Clin Exp Allergy 1985;15:221-234.
68. 68. Peters SP, Schleimer RP, Naclerio RM, Baroody F. Understanding the inflammatory processes in upper allergic airway disease and asthma. J Allergy Clin Immunol 1988;101:S345-S351.
69. 69. Bentley AM, Kay AB, Durham SR. Human late asthmatic reactions. Clin Exp Allergy 1997;27:71-86.
70. 70. Lozewics S, Gomez E, Chalstrey E, Gatand D, Davies RJ. Time course of cellular infiltration in the nasal mucosa during the immediate allergic reaction. Int Arch Allergy Appl Immunol 1991;95:273-277.
71. 71. Kawabori S, Okuda M, Unno T, Nakamura A. Dynamics of mast cell degranulation in human allergic epithelium after provocation with allergen. Clin Allergy 1985;15:509-515.
72. 72. Juliusson S, Pipkom U, Karlsson G, Enerbäck L. Mast cells and cosinophils in the allergic mucosa response to allergen challenge. J Allergy Clin Immunol 1992;90:898-909.
73. 73. Bradding P, Feather IH, Wilson S, et al. Immunolocalization of cytokines in the nasal mucosa of normal and perennial rhinitic subjects. J Immunol 1993;151:3853-3865.
74. 74. Wedi B, Elsner J, Czech W, Butterfield Jh, Kapp A. Modulation of intracellular adhesion molecule 1 expression on the human mast cell line (HMC)-1e by inflammatory mediators. Eur J Allergy Clin Immunol 1996;51:676-684.
75. 75. Papi A. Epithelial ICAM-1 regulation and its role in allergy. Clin Exp Allergy 1997;27:721-724.
76. 76. Ricci M, Matucci A, Rossi O. Source of IL-4 able to induce the developement of Th2-like cells. Clin Exp Allergy 1994;24:930-939.
77. 77. Kay AB. Asthma and inflammation. J Allergy Clin Immunol 1991;87:893-910.
78. 78. Choi KL, Clamann HN. Mast cells, fibroblasts and fibrosis. Immunol Res 1987;6:145-152.
79. 79. Goto T, Befus D, Low R, Bienenstock J. Mast cell heterogeneity in bleomycin-induced pulmonary fibrosis of rats. Am Rev Respir Dis 1984;130:797-802.
80. 80. Wilson JW, Li X. The measurement of reticular basement membrane and submucosal collagen in the asthmatic airway. Clin Exp Allergy 1997;27:363-371.